大分子药物研发 | 序列、专利、文献查询平台通过在 智慧芽Bio生物序列数据库——常规搜索中查询Insulin lispro(赖脯胰岛素,Humalo,优泌乐)序列Sequence Code 31946,得到如下5000条序列、8258条专利和6886篇文…
Insulin lispro, alone (Humalog庐) or as premixture (Humalog Mix25庐 or Humalog Mix50庐) is indicated for the treatment of hyperglycaemia in diabetes mellitus in many countries worldwide. It is a recombinant human insulin analogue and, except for the transposition of two amino acids, is ...
Insulin lispro is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours.Insulin lispro is used to improve blood sugar control in adults and children with diabetes mellitus....
Insulin lispro(赖脯胰岛素,Humalo,优泌乐)是一种快速起效的胰岛素类似物,用于治疗糖尿病,特别是1型和2型糖尿病。它是人胰岛素B链第28位脯氨酸被赖氨酸取代的产物,这种替换使得胰岛素分子更易于聚合,从而在注射后能更快地解聚并释放到血液中,加快其吸收和作用,以快速降低血糖水平。Insulin lispro的作用机制是通过与...
Bex M, Buysschaert M, De Leeuw I, et al.-- Insulin lis- pro (Humalog(R)) in the treatment of diabetes mellitus : overview of Belgian clinical data from global studies. Acta Clin Belg, 1999, 54, 241-245.Bex M, Buysschaert M, De Leeuw I et al (1999) Insulin lispro (Humalog) ...
Detailed Insulin Lispro/Insulin Lispro Protamine dosage information for adults. Includes dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and dialysis adjustments.
部份中文赖脯胰岛素处方资料(仅供参考)英文名:Insulin Lispro商品名:Humalog中文名:赖脯胰岛素注射剂生产商:礼来公司药品类别: 胰腺激素及其它影响血糖药药理作用研究发现赖脯胰岛素与等摩尔胰岛素具有同等的药效,胰岛素的主要作用包括赖脯胰岛素在内是调节葡萄糖的代谢此外在人体的许多组织中所有胰岛素都有几种合成代谢的抑...
Many forms of insulin treat diabetes. They're grouped by how fast they start to work and how long their effects last. Thetypes of insulininclude: Rapid-acting:This type of insulin starts to work in about 15 minutes and lasts for 1 to 5 hours, depending on which type you use. You take...
Use of insulin Lispro in type 2 diabetes - a 6 month expierienceUse of insulin Lispro in type 2 diabetes - a 6 month expieriencedoi:10.1016/S0168-8227(00)81603-4ElzbietaBandurska-StankiewiczandWiolettaZasadowskaSDOSDiabetes Research & Clinical Practice...
赖脯胰岛素(insulin lispro,IL,商品名Humalog)为人胰岛素(human insulin,HI)脯赖换位的重组类似物,是美国礼来(Lilly)公司于1996年首次在瑞士上市的.迄今已获得瑞典,德,英,俄等不少欧洲国家,美国,加拿大和一些拉美国家,以及日本,澳大利亚,新西兰和南非等国的批准并广泛用于临床,普遍反映良好. 顾名思义,此种脯赖换...